SCHEMBL13660689

SCHEMBL13660689

CNC(CNC(=O)C(C)(C)C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASR P41180 1/20 0.38
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ THPO P40225 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ OPRK1 P41145 2/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ ITGAV P06756 2/20 0.31
▸ FOLH1 Q04609 2/20 0.31
▸ NAALAD2 Q9Y3Q0 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19057922 0.79 — —
SCHEMBL13660685 0.78 POLB (0.45) POLBMAPTSMN1; SMN2KDM4EOPRK1
SCHEMBL25356963 0.77 MAPT (0.43) CASRMAPTSMN1; SMN2KDM4ETHRB
SCHEMBL26008141 0.77 MAPT (0.43) CASRMAPTSMN1; SMN2KDM4ETHRB
SCHEMBL31306969 0.77 MEN1 (0.39) POLBMAPTSMN1; SMN2CYP2D6CYP2C19
SCHEMBL13660692 0.77 POLB (0.44) POLBMAPTSMN1; SMN2KDM4EFOLH1
SCHEMBL2682024 0.76 MEN1 (0.51) ACECA1CA2CA7
SCHEMBL1854217 0.76 MEN1 (0.51) ACECA1CA2CA7
SCHEMBL13876912 0.75 APAF1 (0.39) POLBMAPTSMN1; SMN2BLMCYP2D6
Hydrochloric Acid SCHEMBL2681084 0.74 MEN1 (0.50) ACECA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258381-A1 Methods for Determining the Cleavability of Substrates FORSCHUNGSZENTRUM BORSTEL (DE) 2009-10-15 — — US disclosed
US-20090104633-A1 Kit for Highly Sensitive Detection Assays VYZKUMNY USTAV VETERINARNIHO LEKARSTVI (CZ) 2009-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258381-A1 Methods for Determining the Cleavability of Substrates CTSF, ADAM17, ADAM10 CASR 2415/4885POLB 2185/4885MAPT 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback